(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Baxter 2B1314X - Sodium Chloride 0.45% IV Solution Viaflex 1000ml, 14 EA/CA

Baxter # 2B1314X - Sodium Chloride 0.45% IV Solution Viaflex 1000ml, 14 EA/CA
Part Number Baxter 2B1314X
SKU Number CIA7003184
Sell Unit CASE
Ships Within Call for Availability
List Price $87.00
Enter a valid quantity
Product Description

Baxter 2B1314X - Sodium Chloride 0.45% IV Solution Viaflex 1000ml, 14 EA/CA

Sodium Chloride 0.45% IV Solution Viaflex 1000ml, 14 EA/CA

Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The nominal pH is 5.0 (4.5 to 7.0). Composition, osmolarity, and ionic concentration are shown below:

0.45% Sodium Chloride Injection, USP contains 4.5 g/L Sodium Chloride, USP (NaCl) and is hypotonic with an osmolarity of 154 mOsmol/L (calc). It contains 77 mEq/L sodium and 77 mEq/L chloride.

Baxter 2B1314X VIAFLEX Plastic Container

The VIAFLEX plastic container is fabricated from a specially formulated polyvinylchloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.

Sodium Chloride 0.45% IV Solution Dosage And Administration

All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile and nonpyrogenic equipment. As directed by a physician. Dosage, rate, and duration of administration are to be individualized and depend upon the indication for use, the patients age, weight, clinical condition, concomitant treatment, and on the patients clinical and laboratory response to treatment.

When other electrolytes or medicines are added to this solution, the dosage and the infusion rate will also be dictated by the dose regimen of the additions. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Use of a final filter is recommended during administration of all parenteral solutions, where possible.

Do not administer unless the solution is clear and seal is intact. Additives may be incompatible with Sodium Chloride Injection, USP. As with all parenteral solutions, compatibility of the additives with the solution must be assessed before addition. Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Sodium Chloride Injection, USP is appropriate. After addition, check for unexpected color changes and/or the appearance of precipitates, insoluble complexes or crystals.

The instructions for use of the medication to be added and other relevant literature must be consulted. Additives known or determined to be incompatible must not be used. When introducing additives to Sodium Chloride Injection, USP, aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives. After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion. Do not reconnect any partially used containers. Discard any unused portion.

Baxter 2B1314X Sodium Chloride 0.45% IV Solution Overdosage

Excessive administration of 0.45% Sodium Chloride Injection, USP may lead to hypo and hypernatremia, while excessive administration of 0.9% Sodium Chloride Injection, USP may lead to hypernatremia. Both hypo- and hypernatremia can lead to CNS manifestations, including seizures, coma, cerebral edema and death. Excessive administration of Sodium Chloride Injection, USP may lead to sodium overload (which can lead to central and/or peripheral edema). When assessing an overdose, any additives in the solution must also be considered. The effects of an overdose may require immediate medical attention and treatment.

  • Manufacturer: Baxter 2B1314X
  • Application: Replacement Preparation
  • Container Type: Flexible Bag
  • Dosage Form: IV Solution
  • Generic Drug Name: Sodium Chloride
  • Strength: 0.45%
  • Type: Intravenous
  • Volume: 1,000 mL
  • Latex Free Indicator: Not Made with Natural Rubber Latex
  • VIAFLEX Flexible Plastic Bag
  • MADE IN USA
Related Products